Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat

Rhea-AI Summary

Yield10 Bioscience, Inc. (Nasdaq:YTEN) announced that President and CEO Oliver Peoples will participate in the Maxim Group 2022 Virtual Growth Conference from March 28-30, 2022. Dr. Peoples is set to present a corporate overview, available at 9:00 am ET on March 28. Additionally, he will engage in a live fireside chat with Anthony Vendetti at 11:30 am ET on the same day. Investors can register for the conference and request one-on-one meetings with management. Yield10 focuses on agricultural bioscience, developing improved Camelina varieties and high-value genetic traits.

WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022.

Dr. Peoples will present a corporate overview which will become available as of 9:00 am ET on Monday, March 28, 2022.   The presentation can be viewed here.

In addition, Dr. Peoples will participate in a live fireside chat with Anthony Vendetti, Director of Research and Senior Healthcare Analyst at Maxim Group at 11:30 am ET (Track 2) on Monday, March 28, 2022.

Investors can view the presentation and the fireside chat by registering for the conference here and also request a one-on-one meeting with management to be arranged following the conclusion of the conference.

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina to produce feedstock oils, PHA bioplastics and omega-3 (DHA+EPA) oils and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

(YTEN-G)

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

FAQ

What is the date of the Yield10 Bioscience presentation at the Maxim Group 2022 Virtual Growth Conference?

The presentation will be on March 28, 2022, at 9:00 am ET.

Who will lead the fireside chat at the Maxim Group 2022 conference?

Oliver Peoples, President and CEO of Yield10, will participate in the fireside chat with Anthony Vendetti.

Where can I view the Yield10 presentation during the Maxim Group conference?

The presentation will be available online through registration for the conference.

What is Yield10 Bioscience focused on developing?

Yield10 focuses on developing improved Camelina varieties and high-value genetic traits for agriculture.

How can investors meet with Yield10 management during the conference?

Investors can request one-on-one meetings with management after the conference through registration.